Novo Nordisk A/S Common Stock (NVO)
Operating Cash Flow Growth
35.34%
Quarterly · Period ending:
NVO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported35.34%period ending
Latest reported35.34%period ending
NVO Quarterly Cash from Operations YoY % (0.26% → 35.34%)
Year-over-year change
High-resolution chart · PNG
NVO operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 35.3414% | |
| -2.0617% | |
| -38.0619% | |
| 5.1471% | |
| -19.2424% | |
| 71.7968% | |
| 28.7928% | |
| 7.04% | |
| 76.726% | |
| -51.989% | |
| 34.5022% | |
| 69.0086% | |
| 19.2646% | |
| 26.4055% | |
| 335.3663% | |
| 12.7028% | |
| -5.1237% | |
| 109.5602% | |
| -1,854.0698% | |
| 22.855% | |
| 4.0971% | |
| 12.4151% | |
| -96.6699% | |
| 4.9017% | |
| 61.3206% | |
| 1.2336% | |
| -30.3157% | |
| 43.6268% | |
| -4.6354% | |
| 0.7641% | |
| 22.878% | |
| -10.0766% | |
| 55.8762% | |
| -18.8709% | |
| -45.9159% | |
| -14.9319% | |
| -30.2131% | |
| 61.8462% | |
| 10.2184% | |
| 25.6535% | |
| 21.0707% | |
| 82.0507% | |
| 38.5975% | |
| -0.8937% | |
| 47.3723% | |
| 0.9093% | |
| 35.9084% | |
| 96.1879% | |
| 11.5612% | |
| -42.447% | |
| 254.8217% | |
| -21.9166% | |
| 25.073% | |
| 2.2415% | |
| -61.9694% | |
| 2.6825% | |
| 28.5147% | |
| 35.3759% | |
| -18.8379% | |
| 22.7287% | |
| 7.2426% | |
| 20.728% | |
| 36.8965% | |
| 25.382% | |
| 62.0015% | |
| 2.001% | |
| 10.4672% | |
| 37.5668% | |
| -10.7318% | |
| 35.1606% | |
| 29.0602% | |
| 4.9229% | |
| 102.4471% | |
| 20.3267% | |
| 599.2687% | |
| -0.9135% | |
| -18.2635% | |
| 21.8537% | |
| -84.7306% | |
| 21.2648% | |
| -15.7437% | |
| 55.6351% | |
| 11.9234% | |
| 17.0313% | |
| 21.999% | |
| 0.2646% |